New York S 3350: Requires practitioners who administer naloxone or another overdose reversal agent to a patient to report the administration of the agent to the prescription monitoring program registry

Status: REFERRED TO HEALTH (as of 2024-01-03)

State: New York · Session: 2023-2024 · Bill: S 3350

Sponsors: Nathalia Fernandez

View New York S 3350 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.